CUS and CURAS Related Headlines
Go Back- Curasight reports tumor uptake in brain cancer trial for uTREAT drug
- Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
- Curasight doses first patient in brain cancer trial with uTREAT therapy
- Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer
CUS and CURAS Related Press Releases
Go Back- Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
- Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer
